Table 2.

Treatment outcome.

D-1D1Overall
NE, not evaluable2 (6.5%)1 (25.0%)3 (8.6%)
PD, progressive disease8 (25.8%)1 (25.0%)9 (25.7%)
ORR (partial response/remission)8 (25.8%)1 (25.0%)9 (25.7%)
SD, stable disease13 (41.9%)1 (25.0%)14 (40.0%)